Showing 1 - 12 results of 12 for search 'Chih-Wei Yen', query time: 0.05s Refine Results
  1. 1
    Experimental Investigation of the Performance of a Hermetic Screw-Expander Organic Rankine Cycle

    Experimental Investigation of the Performance of a Hermetic Screw-Expander Organic Rankine Cycle by Sung-Wei Hsu, Hsiao-Wei D. Chiang, Chih-Wei Yen

    Published 2014-09-01
    Get full text
    Article
  2. 2
    Determination of the Minimum Effective Dosages of Praziquantel, Albendazole, and Mebendazole Against Clonorchis Sinensis Infection in Rats

    Determination of the Minimum Effective Dosages of Praziquantel, Albendazole, and Mebendazole Against Clonorchis Sinensis Infection in Rats by Ping-Chin Fan, Chin-Cheng Wu, Ping Huang, Chih-Wei Yen

    Published 2005-10-01
    Get full text
    Article
  3. 3
    Prenatal Group B Streptococcus Test Using Real-Time Polymerase Chain Reaction

    Prenatal Group B Streptococcus Test Using Real-Time Polymerase Chain Reaction by Chi-Feng Wei, Bo-Ching She, Hung-Shuo Liang, Qing-Dong Ling, Chen-Yuan Tsai, Chih-Wei Yen, Hsueh-Yin Wu, Ming-Song Tsai

    Published 2009-06-01
    Get full text
    Article
  4. 4
    Upregulation of bone morphogenetic protein 1 is associated with poor prognosis of late-stage gastric Cancer patients

    Upregulation of bone morphogenetic protein 1 is associated with poor prognosis of late-stage gastric Cancer patients by Yung-Yu Hsieh, Shui-Yi Tung, Hung-Yu Pan, Chih-Wei Yen, Huang-Wei Xu, Yi-Fang Deng, Ying-Jhen Lin, Wan-Ting Hsu, Cheng-Shyong Wu, Chin Li

    Published 2018-05-01
    Get full text
    Article
  5. 5
    The effectiveness and safety of vedolizumab induction for moderate to severe ulcerative colitis for Asia patient: A real practice observational study

    The effectiveness and safety of vedolizumab induction for moderate to severe ulcerative colitis for Asia patient: A real practice observational study by Chia-Jung Kuo, Puo-Hsien Le, Wei-Chen Tai, Keng-Liang Wu, Hsu-Heng Yen, Chih-Wei Yen, Shui-Yi Tung, Chen-Shuan Chung, Ming-Yao Su, Cheng-Tang Chiu

    Published 2022-09-01
    Get full text
    Article
  6. 6
    Did AFP-L3 save ultrasonography in community screening?

    Did AFP-L3 save ultrasonography in community screening? by Chih-Wei Yen, Yuan-Hung Kuo, Jing-Houng Wang, Kuo-Chin Chang, Kwong-Ming Kee, Shu-Feng Hung, Yi Chen, Lin-San Tsai, Shu-Chuan Chen, Chao-Hung Hung, Sheng-Nan Lu

    Published 2018-10-01
    Get full text
    Article
  7. 7
    Incidence, risk factors and impact on virological response of anemia in chronic genotype 2 hepatitis C receiving sofosbuvir plus ribavirin

    Incidence, risk factors and impact on virological response of anemia in chronic genotype 2 hepatitis C receiving sofosbuvir plus ribavirin by Chi-Ching Chen, Shui-Yi Tung, Kuo-Liang Wei, Chien-Heng Shen, Te-Sheng Chang, Wei-Ming Chen, Huang-Wei Xu, Chih-Wei Yen, Yi-Hsing Chen, Sheng-Nan Lu, Chao-Hung Hung

    Published 2020-01-01
    Get full text
    Article
  8. 8
    Long-term risk of primary liver cancers in entecavir versus tenofovir treatment for chronic hepatitis B

    Long-term risk of primary liver cancers in entecavir versus tenofovir treatment for chronic hepatitis B by Te-Sheng Chang, Yao-Hsu Yang, Wei-Ming Chen, Chien-Heng Shen, Shui-Yi Tung, Chih-Wei Yen, Yung-Yu Hsieh, Chuan-Pin Lee, Meng-Ling Tsai, Chao-Hung Hung, Sheng-Nan Lu

    Published 2021-01-01
    Get full text
    Article
  9. 9
    High viral load predicts virologic failure in chronic genotype 2 hepatitis C virus-infected patients receiving glecaprevir/pibrentasvir therapy

    High viral load predicts virologic failure in chronic genotype 2 hepatitis C virus-infected patients receiving glecaprevir/pibrentasvir therapy by Wei-Ming Chen, Kuo-Liang Wei, Shui-Yi Tung, Chien-Heng Shen, Te-Sheng Chang, Chih-Wei Yen, Yung-Yu Hsieh, Wen Nan Chiu, Jin Hung Hu, Sheng-Nan Lu, Chao-Hung Hung

    Published 2020-11-01
    Get full text
    Article
  10. 10
    Sofosbuvir/velpatasvir is an effective treatment for patients with hepatitis C and advanced fibrosis or cirrhosis in a real-world setting in Taiwan

    Sofosbuvir/velpatasvir is an effective treatment for patients with hepatitis C and advanced fibrosis or cirrhosis in a real-world setting in Taiwan by Yu-Ting Huang, Yung-Yu Hsieh, Wei-Ming Chen, Shui-Yi Tung, Kuo-Liang Wei, Chen-Heng Shen, Kao-Chi Chang, Chung-Kuang Lu, Chih-Wei Yen, Sheng-Nan Lu, Chao-Hung Hung, Te-Sheng Chang

    Published 2021-06-01
    Get full text
    Article
  11. 11
    Clinical utility of hepatitis C virus core antigen assay in the monitoring of direct-acting antivirals for chronic hepatitis C.

    Clinical utility of hepatitis C virus core antigen assay in the monitoring of direct-acting antivirals for chronic hepatitis C. by Sheng Feng Lin, Shui-Yi Tung, Kuo-Liang Wei, Chien-Hung Chen, Tsung-Hui Hu, Chien Heng Shen, Te-Sheng Chang, Wei-Ming Chen, Chih-Wei Yen, Jing-Houng Wang, Chao-Hung Hung, Sheng-Nan Lu

    Published 2020-01-01
    Get full text
    Article
  12. 12
    Comparison of 8- versus 12-weeks of glecaprevir/pibrentasvir for Taiwanese patients with hepatitis C and compensated cirrhosis in a real-world setting.

    Comparison of 8- versus 12-weeks of glecaprevir/pibrentasvir for Taiwanese patients with hepatitis C and compensated cirrhosis in a real-world setting. by Yung-Hsin Lu, Chung-Kuang Lu, Chun-Hsien Chen, Yung-Yu Hsieh, Shui-Yi Tung, Yi-Hsing Chen, Chih-Wei Yen, Wei-Lin Tung, Kao-Chi Chang, Wei-Ming Chen, Sheng-Nan Lu, Chao-Hung Hung, Te-Sheng Chang

    Published 2022-01-01
    Get full text
    Article

Search Tools: